Early WAKE-up Predictors After Out-of-Hospital Cardiac Arrest

NCT06979700 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2025-11-18

No results posted yet for this study

Summary

WAKE-OHCA is a prospective observational substudy of the Danish Out-of-Hospital Cardiac Arrest (DANOHCA) trial, identifier NCT05895838. The aim is to collect early neuromonitoring data to identify key predictors of successful wake-up.

Conditions

  • Cardiac Arrest (CA)
  • Anoxic Brain Injury
  • Comatose Survivors of Cardiac Arrest
  • EEG
  • Pupillometry
  • Optic Nerve Sheath Diameter
  • Transcranial Doppler Ultrasound
  • Neurological Outcome

Interventions

DIAGNOSTIC_TEST

Automated Pupillometry

Measurements will be performed on comatose participants at 0-6 hours, 20-28, 44-52 and 66-72 hours after enrolment for both pupils and include: Neurological pupil index, pupillary size, pupillary minimum diameter, pupillary constriction amplitude, pupillary constriction velocity, pupillary maximum constriction velocity, pupillary latency and pupillary dilation velocity.

DIAGNOSTIC_TEST

Transcranial Doppler Ultrasound

Measurements will be performed on comatose participants at 0-6 hours, 20-28, 44-52 and 66-72 hours after enrolment on both middle cerebral arteries and include the following: Peak systolic velocity, end diastolic velocity, mean velocity, pulsatility index and resistance index.

DIAGNOSTIC_TEST

Optic Nerve Sheath Diameter

Measurements will be performed on comatose participants at 0-6 hours, 20-28, 44-52 and 66-72 hours after enrolment on both eyes using ultrasound and include the following: optic nerve sheath diameter of right and left side and mean optic nerve sheath diameter.

DIAGNOSTIC_TEST

Continuous EEG and EEG Reactivity

Continuous 4-channel EEG will be established on participants as soon as possible within 0-6 hours. EEG will be stopped at successful extubation or when 72 hours has passed since study inclusion. EEG Reactivity will be performed on comatose participants at the following times: 0-6, 20-28, 44-52 and 66-72 hours after study inclusion. Reactivity includes 7 standardized stimuli, including 1 visual, 3 auditive and 3 pain stimuli. EEG data will be reviewed in Stratus EEG Analysis (Kvikna Mediacal ehf. version 5.1). Timestamps for EEG-reactivity will be manually inserted in the file. EEG Reactivity will be analysed quantitatively by power spectrum analyses performed in LabVIEW 2016 (National Instruments) according to the principles of a previous method (PMID: 36041343). Background activity within 5 minutes following reactivity stimuli, prioritizing time periods without artifacts, will be analysed by power spectrum analyses, Mindray quantitative analysis and manually analyzed by experts.

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • University of Aarhus

    lead OTHER

Principal Investigators

  • Christian Hassager, MD, DMSc · Department of Cardiology, Rigshospitalet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-13
Primary Completion
2027-09-30
Completion
2027-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06979700 on ClinicalTrials.gov